PharmExec14h
FDA Approves GSK’s Blujepa for Uncomplicated Urinary Tract Infections
Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...
Managed Healthcare Executive13h
FDA Approves UTI Antibiotic, Blujepa
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
FDA Approves GSK's Oral Antibiotic For Urinary Tract Infections For Females Aged 12 Years And Older
The FDA approved GSK's Blujepa for uncomplicated UTIs in female adults and pediatric patients, with phase 3 trials showing strong efficacy vs. nitrofurantoin.
Medscape2d
Amoxicillin-Clavulanate: Not a Good First-Line Choice for UTIs
Clinicians frequently treat acute uncomplicated urinary tract infections (UTIs ... resistance to these agents is emerging, and although nitrofurantoin is suggested as a fluoroquinolone-sparing ...
BioSpace21h
GSK Wins FDA Nod for First Oral UTI Antibiotic in Almost 30 Years
Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...
clinicaladvisor.com21d
IDSA 2011 Guideline for Uncomplicated UTI Still Clinically Relevant
Guideline-recommended first-line treatments include nitrofurantoin, trimethoprim-sulfamethoxazole, and fosfomycin. However, ciprofloxacin and levofloxacin are most commonly used to treat UTI ...
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...
wrtv13h
FDA approves first new antibiotic treatment for UTIs in decades
A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...